Cipla USA, Inc. recalls Lanthanum Carbonate chewable tablets
- Recalling company
- Cipla USA, Inc.
- Product
- Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.
- Reason
- Failed stability specifications: Out of specification for hardness test
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Oct 24, 2025
- Reported
- Dec 17, 2025
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot# NB240314, exp 12/31/2025
- Company location
- Warren, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0218-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0218-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.